This week, cataract extractions are linked to lower dementia risk, a new model for studying oculocutaneous albinism is revealed, and patients express satisfaction with a vision self-test smartphone app. Source: AAO
The top 15 Editors’ Choice reviews in 2021, including several articles on COVID-19 and vaccinations, and implications for eye disease. Source: AAO
Following a Toxoplasma gondii infection outbreak in Santa Maria City, Brazil, the authors investigated the prevalence of ocular abnormalities in a consecutive case series of 187 vertically exposed infants. Source: AAO
This systematic review and meta-analysis of the literature evaluated whether combined epithelial retinal membrane (ERM) and internal limiting membrane (ILM) peeling offered advantages in postoperative visual outcomes over ERM peeling alone. Source: AAO
Investigators compared the rate of ocular complications, particularly lagophthalmos, between preseptal and pretarsal botulinum toxin injections in patients with benign essential blepharospasm (BEB). Source: AAO
This study analyzed visual and refractive outcomes in patients with keratoconus undergoing cataract surgery with a toric IOL implantation. Investigators compared IOL prediction accuracy between newer keratoconus-adjusted formulas and several conventional formulas. Source: AAO
Investigators conducted a post hoc analysis evaluating panretinal photocoagulation (PRP) treatment and re-treatment patterns in the Phase 3 randomized, controlled RIDE and RISE trials of ranibizumab. Source: AAO
This prospective study was conducted to evaluate the progression and magnitude of change in IOP in patients undergoing surgery for glaucoma. Source: AAO
Predictive errors after pediatric IOL implantation remain highly variable. This retrospective case series study compared the accuracy of the Barrett Universal II formula with the Holladay 2, Hoffer Q, and SRK/T in predicting postoperative refraction for pediatric IOL implantation. Source: AAO
This week, an educational website on uveitic glaucoma is launched, patients express satisfaction with remote consultations, and a gene therapy trial for AMD enters phase III enrollment. Source: AAO
Tel: 518-580-0553
Get Directions »
Tel: 518-580-0553
Get Directions »
Tel: +1 (518) 580-0553
Get Directions »
